• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnebulo Pharmaceuticals
    Picture of Anebulo Pharmaceuticals logo

    ANEB — Anebulo Pharmaceuticals Share News

    $0.290.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $11.83m
    • Enterprise Value
      $2.79m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANEB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANEB Dividends
    • Brief: Anebulo Pharmaceuticals Says On Track To Commence Phase 2 Proof-Of-Concept Clinical Trial With Aneb-001 In Q4

      21/06/2021 21:13
    • Brief: Anebulo Pharmaceuticals Says Aron English Reports 34.4% Stake In Co

      17/05/2021 22:22
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

      07/05/2021 09:00
    • Brief: Anebulo Pharmaceuticals Announces Pricing Of Initial Public Offering

      07/05/2021 01:58
    • Brief: Anebulo Pharmaceuticals Inc - Anticipate That IPO Price Will Be Between $6.00 And $8.00 Per Share Of Common Stock

      26/04/2021 21:51
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.